Stage III Breast Cancer Recruiting Phase 1 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT033643484-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast CancerTreatment